FindTrial
Sign In

Construction of rational drug use evaluation system for nosocomial acquired infections

Construction of rational drug use evaluation system for nosocomial acquired infections

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082091
Enrollment
Unknown
Registered
2024-03-20
Start date
2022-12-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases associated with bacterial infections

Interventions

antibiotic combination group:NA

Sponsors

Beijing Friendship, Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Patients with bacterial infection from 2015.1 to 2022.6 and have an admission time of more than 24 hours. (2) The occurrence of antibiotic combination

Exclusion criteria

Exclusion criteria: (1) The underlying disease is a blood system disease, immune system disease or application of immune system modulator;

Design outcomes

Primary

MeasureTime frame
Frequency of prescription;Prescription effectiveness;—

Countries

China

Contacts

Public ContactYan Dan

Beijing Friendship, Hospital Capital Medical University

yd277@126.com+86 134 8867 8873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026